Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm
The drug company will effectively give up on marketing Aduhelm, [...]
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Officials cited data showing the new Alzheimer’s drug has serious [...]
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
The Alzheimer’s Association has pushed relentlessly to get broad access [...]
Financial Planning for People With Chronic Diseases
Financial planning for people with chronic diseases is complicated and [...]
Alzheimer’s Drug Aduhelm Faces Crucial Medicare Decision
Medicare officials are trying to determine whether to cover Aduhelm, [...]
How to Cope With Medicare’s Rising Costs
A higher Medicare premium in 2022 is just part of [...]
Biden Focuses on How Spending Bill Would Lower Drug Costs
President Biden emphasized how the bill would lower prescription drug [...]
Build Back Better Act Would Patch Holes in Health Coverage
Taken together, the provisions in the social policy bill represent [...]
Inflation and Retirement: How to Protect Your Savings
With prices rising at their fastest rate in decades, people [...]
Biogen’s Alzheimer’s drug is unlikely to win E.U. approval.
The drug, Aduhelm, has been mired in controversy since it [...]